Navigation Links
Novel Device Shows Promise for Reducing HIV Among Men
Date:5/12/2011

NEW YORK, May 12, 2011 /PRNewswire-USNewswire/ -- Promising study results published in the May issue of JAIDS show that a novel medical device has the potential to revolutionize how male circumcision services are offered in countries hardest hit by the HIV epidemic. Conducted by EngenderHealth, a global reproductive health organization, and Weill Cornell Medical College, the study found the device, known as the Shang Ring, is highly acceptable to men and safe for further study in Africa.  

"These positive results confirm that the Shang Ring is safe and acceptable," said Dr. Mark Barone, Senior Clinical Advisor at EngenderHealth. "Not only is it a sutureless procedure with little or no bleeding, but it is faster to perform and takes less time to heal than conventional circumcision. Evidence is also mounting that the Shang Ring will be feasible in low-resource settings."

The Shang Ring is a disposable device consisting of two concentric plastic rings that lock together over the foreskin. Surgical circumcisions typically take 20-40 minutes to complete and pose risks related to bleeding. But unlike conventional surgery, the Shang Ring does not require sutures, involves minimal bleeding and offers patients shorter procedure times (3-5 minutes).

"One of the unique and compelling features of the Shang Ring is that it is so simple to perform that all health care professionals, not only surgeons, could be trained to safely use the device," said Dr. Marc Goldstein, Professor of Urology, and Reproductive Medicine at Weill Cornell Medical College and Surgeon-in-Chief, Male Reproductive Medicine and Surgery, New York Presbyterian Hospital/Weill Cornell Medical Center. "This is critical in countries where trained surgeons and physicians are scarce."

Evidence has shown that male circumcision can reduce the risk of heterosexual HIV transmission by up to 64%. The World Health Organization and the Joint UN Programme on HIV/AIDS (UNAIDS) recommend that countries include male circumcision as part of their HIV prevention programs. But because surgical circumcision requires a trained physician or surgeon, circumcision rates remain low in many developing countries.

Through a grant to FHI from the Bill & Melinda Gates Foundation, EngenderHealth and Cornell are working with FHI to conduct additional studies to better understand how the Shang Ring might transform the provision of male circumcision services in Africa. The research consists of a safety study and a randomized controlled trial to compare the Shang Ring with conventional surgery.

About EngenderHealth

EngenderHealth is a leading global reproductive health organization working to improve the quality of health care in the world's poorest communities. EngenderHealth empowers people to make informed choices about contraception, trains health providers to make motherhood safer, promotes gender equity, enhances the quality of HIV and AIDS services, and advocates for positive policy change. The nonprofit organization works in partnership with governments, institutions, communities, and health care professionals in 26 countries. EngenderHealth has been leading research on the national male circumcision program in Kenya since it launched in 2008. For more information, visit www.engenderhealth.org/mc.

About Weill Cornell Medical College

Weill Cornell Medical College, Cornell University's medical school located in New York City, is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine, locally, nationally and globally. Physicians and scientists of Weill Cornell Medical College are engaged in cutting-edge research from bench to bedside, aimed at unlocking mysteries of the human body in health and sickness and toward developing new treatments and prevention strategies. In its commitment to global health and education, Weill Cornell has a strong presence in places such as Qatar, Tanzania, Haiti, Brazil, Austria and Turkey. Through the historic Weill Cornell Medical College in Qatar, the Medical College is the first in the U.S. to offer its M.D. degree overseas. Weill Cornell is the birthplace of many medical advances — including the development of the Pap test for cervical cancer, the synthesis of penicillin, the first successful embryo-biopsy pregnancy and birth in the U.S., the first clinical trial of gene therapy for Parkinson's disease, and most recently, the world's first successful use of deep brain stimulation to treat a minimally conscious brain-injured patient. Weill Cornell Medical College is affiliated with NewYork-Presbyterian Hospital, where its faculty provides comprehensive patient care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The Medical College is also affiliated with the Methodist Hospital in Houston. For more information, visit weill.cornell.edu.


'/>"/>
SOURCE EngenderHealth
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study
2. Amira Pharmaceuticals Announces Completion of Phase 1 Clinical Study for AM152, A Novel LPA1 Receptor Antagonist
3. International Leaders in Electrophysiology Discuss Improving Atrial Fibrillation Treatment Using Novel Endoscopically Guided Laser Ablation Catheter
4. MonoSol Rx and KemPharm to Develop Novel PharmFilm® Product for ADHD
5. Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis
6. Shrink Nanotechnologies Announces That Critical Cell Align Tissue Engineering Platform Patent as Well as IP on a Novel Immunoassay Substrate Material Has Been Filed With the USPTO
7. Theramed Secures Exclusive Canadian Distribution Rights for Two Novel Obstetrics Products from Glenveigh
8. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
9. Telik Announces Presentation of New Data on the Characterization of Novel Ezatiostat (TELINTRA®, TLK199) Analogs at American Association for Cancer Research Annual Meeting
10. Two Novel Lilly Molecules Target Genetic Mutations That Can Lead to Cancer
11. Caliper Life Sciences Launches Novel COX-2 Probe to Enable Personalized Medicine Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
(Date:6/23/2016)... ITASCA, Ill. , June 23, 2016  In a startling ... states are failing their residents by lacking a comprehensive, proven plan ... , a definitive ranking of how states are tackling the ... rating to only four states – Kentucky , ... and Vermont . Of the 28 failing states, ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The ... published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , ...
Breaking Medicine News(10 mins):